12. De Gennaro Colonna V., et al., Reduced Growth Hormone Releasing Factor (GHRF)-like immunoreactivity and GHRF gene expression in the Hypothalamus of aged rats.  Peptides 1989; 10:705-708.

13. Iovino M, et al., Repetitive growth hormone releasing hormone administration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging. JCEM 1989; 69:910-913.

14. Bercu BB. et al., Role of selected endogenous peptides in growth hormone releasing hexapeptide (GHRP-6) activity: analysis of GHRH, TRH and GnRh. Endocrinology 1992; 130:2579-2586.

15. Anderson Juul, Jens O.L, Jorgensen, Growth hormone in adults.  Cambridge University Press 1996.

16. Bercu, BB, Walker, R., Growth Hormone Secretagogues in Clinical practice, Marcel Dekker, New York 1998.

17. Pearlman, R, Bewley T., Stability and characterization of human growth hormone Pharmaceutical Biotechnology Vol. 5 p 1-58, 1993

18. Delgado, Nick Grow Young and Slim, Lake Forest CA Health Wellness Studios Inc 2000.

19. Et al. lower risk of cancer: Journal of Clinical Endocrinology & Metabolism, August 1998, Volume 83, and a follow-up study reported in  JCEM Vol. 84, June 1999 in 46 giant

20. Grinberg, A et al, Guilt by association of using GH not a cause. Journal Endocrinology, Invest 1999 22 (5 suppl) 64-73.

21. Vance M. et al. GH Therapy in adults and children. NEJM Oct 14, 1999.

22. Shalet SM, Brennan BM. Growth hormone and malignancy. Horm Res 1997; 48 Suppl 4:29-32

23. Beentjes et al GH therapy increase IGF-1, no increase in colon cell proliferation. Clinical Endocrinology 2000 Apr 52 (4):457-62

24. Wu et al inhibition of DNA synthesis by IGFBP-3 Journal of GH and IGF Research Oct. 99.

25. Cohen et al Novel partners and functions of IGFBP-3 J. of GH and IGF Research Oct 99

26. Mannharadt et al., Functional Inactivation of IGFBP-3 by the viral oncoprotein E7 J. or GH & IGF Research Oct 99.

27. Ma J et al Prospective Study of Colorectal Cancer Risk in men and plasma levels of IGF-1 and IGFBP-3 Journal of the National Cancer Institute Vol 91, No 7 April 7, 1999, 620-25.

28. Schaefer et al Lowest IGF-1 had highest incidence of Prostate cancer, no association of IGF-1 Science Aug 1998.